Background: Because green tea reduces cardiovascular and cerebrovascular risk, the purpose of this study aimed to elucidate the effect of green tea catechins (GTC) on endothelial dysfunction in smokers.
he vascular endothelium is an active and important tissue that controls many important functions, including the regulation of vascular tone and maintenance of blood circulation, fluidity, coagulation and inflammatory responses. 1,2 Endothelial function is influenced by numerous cardiovascular risk factors 3 and is impaired in smokers, even those who are otherwise healthy. 4,5 Endothelial dysfunction is independently related to future cardiovascular events and the prognosis of cardiovascular diseases. 6, 7 Although the mechanisms of endothelial dysfunction remain uncertain, an imbalance between increased oxidative stress and impaired antioxidant mechanism, especially inactivation of nitric oxide (NO) by superoxide anion and other reactive oxygen species, may contribute to the promotion of atherosclerosis and the pathogenesis of cardiovascular disease. 6,8, 9 Because green tea has been found to reduce both cardiovascular and cerebrovascular risk, the aim of this study was to elucidate the effect of green tea catechins (GTC) on the impaired endothelial function, as reflected by forearm blood flow (FBF), in smokers exposed to enormous oxidative stress.
Methods

Subjects
We studied 30 healthy male smokers who had a history of 10 or more pack-years (1 pack-year defined as smoking 20 cigarettes/day for 1 year or the equivalent). All participants were healthy and not taking any drugs or supplements. By examination before entering the study, those with diabetes mellitus (fasting blood sugar >126 mg/dl), hypercholesterolemia (fasting total cholesterol >220 mg/dl, low-density lipoprotein cholesterol >140 mg/dl, high-density lipoprotein cholesterol <40 mg/dl or triglycerides >150 mg/dl) or arterial hypertension (>140 mmHg systolic or >90 mmHg diastolic blood pressure) based on National Heart Lung and Blood Institute clinical guidelines were excluded from the study.
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Study Protocol
The study protocol was approved by the Institutional Review Committee on Human Research, Kyushu University and informed consent was given by each patient.
All subjects were randomly divided into 3 groups to receive 3 types of 340-ml tea (Kao Corporation, Tokyo, Japan) containing different daily doses of GTC (catechin-free group: 0 mg; medium-dose group: 80 mg; equivalent to 1 cup of green tea; high-dose group: 580 mg; equivalent to several cups of green tea; Table 1 ).
The subjects maintained their usual diet and lifestyle, excluding all beverages and supplements that could influence vasomotor function except for water, and were provided the tea beverages throughout the entire study. FBF was measured 4 times on day 0 (basal measurement), at 2 h (acute effect), and on day 7 and day 14 (long-term effects) after green tea intake. The acute effects were examined at 2 h after consumption of the tea after the basal measurement was completed. The chronic effects were examined before having the day's tea on the experimental day to determine trough levels of the effect of GTC after receiving tea daily for 1 and 2 weeks.
Measurement of FBF
The subjects fasted overnight and did not smoke for 12 h before the examination of vascular function. FBF (ml · min −1 · 100 ml −1 of forearm volume) was measured by a mercuryfilled strain-gauge plethysmograph (DE Hokanson Inc, Bellevue, WA, USA) with the venous-occlusion technique as reported previously. 10,11 Briefly, a catheter was inserted into the brachial artery for the infusion of drugs or saline. The basal FBF measurement was obtained from the rate of increase while venous return from the forearm was prevented by inflation of a cuff on the upper arm with the venous occlusion pressure at 50 mmHg. Flow measurements were recorded for 7 s every 15 s, and the average of 4 measurements was used for the analysis. Thereafter, an incremental dose of acetylcholine (ACh: Daiichi Pharmaceutical Corporation, Tokyo, Japan) was infused at doses of 3, 10 and 30 μg/min for 5 min to determine the endothelium-dependent vasodilatation, and sodium nitroprusside (SNP: Maruishi Pharmaceutical Co Ltd, Osaka, Japan) was infused at doses of 0.3, 1.0 and 3 μg/min for 5 min to determine the endothelium-independent vasodilatation.
Biochemical Analyses
Blood samples were collected from the subjects at baseline and before FBF measurement and stored at -80°C until assayed. The plasma levels of the NO compounds (NOx: NO2 − + NO3 − ) and asymmetrical dimethylarginine (ADMA) were measured using high-performance liquid chromatography methods described elsewhere. 12, 13 High-sensitivity C-reactive protein (hsCRP) was quantified by latex-enhanced nephelometry with a Behring Nephelometer Analyzer System. Lipid peroxides (malondialdehyde and 4-hydroxynonenal: MDA + 4HNE: Calbiochem, CA, USA), soluble CD40 ligand (sCD40L: Biosource International, Camarillo, CA, USA), monocyte chemotactic protein-1 (MCP-1: RayBiotech Inc, Norcross, GA, USA) and macrophage migration inhibitory factor (MIF: R&D Systems Inc, Minneapolis, MN, USA), were measured by ELISA methods. The biochemical measurements were duplicated and the averages used for the analysis.
Statistical Analysis
Data are expressed as the means ± SEM unless otherwise indicated. One-way ANOVA was used to compare the baseline clinical characteristics among the 3 groups. The effect of GTC on FBF responses for graded doses of ACh or SNP in each group and the changes in biochemical parameters were compared by 2-way ANOVA for repeated measures followed by Bonferroni correction. Values of P<0.05 were considered to be significant. Table 2 lists the baseline characteristics of the study subjects. There were no significant differences among the 3 groups.
Results
Subject Characteristics
Acute Effect of GTC on FBF
The FBF responses to ACh and SNP were measured at 2 h after tea intake to evaluate the acute effects (Figures 1,2) . Intra-arterial infusions of ACh and SNP did not significantly alter mean arterial pressure or heart rate in any group (data not shown). The graded dose of ACh and SNP resulted in progressive increases in the FBF of all subjects; however, significant differences in the basal FBF response to ACh or SNP were not seen. The vasodilator response to ACh significantly increased at 2 h after the intake of high-dose GTC ( Figure 1c) ; however, no change was seen in the GTC-free and medium-dose groups (Figures 1a,b) . The response to SNP was not significantly affected by short-term treatment A catechin-free beverage contains 0 mg of GTC. The composition of these beverages other than the green tea catechins is same among the 3 groups.
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with any dose of GTC ( Figure 2 ).
Chronic Effect of GTC on FBF
The chronic effect of GTC was assesses by measuring the FBF response to ACh and SNP on days 7 and 14 ( Figures 3,  4) . No increase in FBF was observed in either the GTC-free or medium-dose GTC groups (Figures 3a, b ), but compared with before treatment, the FBF response to ACh was significantly increased in the high-dose GTC group (Figure 3c) . The FBF response to SNP was not significantly affected by long-term treatment with GTC (Figure 4) , which result indicates that GTC did not affect endothelial-independent vasodilatation. Figure 5 shows the plasma levels of NOx, ADMA, and MDA + 4-HNE in each group. In the high-dose group, an increase in NOx and decreases in ADMA and MDA + 4-HNE were time-dependently observed in comparison with the other groups. Table 3 shows the alteration in biochemical parameters that are associated with atherosclerosis in vivo. The high-dose group showed dose-dependent decreases in the levels of MCP-1, MIF, hsCRP and sCD40L in comparison with the other 2 groups. Significant positive relationships were observed between the maximal improvement of FBF response to ACh and the changes in the level of NOx after 2 h (r=0.812, P=0.004), and on days 7 (r=0.824, P=0.003) and 14 (r=0.741, P=0.014), and significant negative relationships were recognized between the maximal FBF improvement and changes in the levels of ADMA and MDA + 4-HNE after 2 h (ADMA: r= 0.758, P=0.011, MDA + 4-HNE: r=0.633, P=0.049) and on days 7 (ADMA: r=0.899, P=0.001, MDA + 4-HNE: r=0.770, P=0.009) and day 14 (ADMA: r=0.802, P=0.005, MDA + 4-HNE: r=0.636, P=0.048), in the high-dose group. However, no relationships between the levels of MCP-1, MIF and sCD40L and the improvement in FBF were recognized in the high-dose group. Moreover, no significant correlations were observed between the changes in any biochemical biomarkers and the improvement in the FBF responses in the other 2 groups.
Assessment of Biochemical Changes After Administration of GTC
Discussion
The present study showed that (1) acute and chronic consumption of high-dose GTC ameliorates ACh-induced FBF in male smokers, but that (2) there was no change in the FBF of patients receiving the medium-or zero dose of GTC, and that (3) high-dose GTC increased NO production and decreased ADMA, oxidative stress and atherosclerotic biomarkers in comparison with the other groups. GTC supplementation resulted in an improvement in forearm endothelial function in these healthy male smokers, probably by scavenging free radicals and/or by mediating an increase in NO production. These results support the epidemiological finding of an inverse relationship between green tea consumption and cardiovascular mortality. 14 
Smoking, Oxidative Stress and Endothelial Function
Smoking is a most important cardiovascular risk factor for the development of atherosclerosis, and is associated with coronary and peripheral vascular disease 15 because tobacco smoke contains a large number of oxidants and many of the adverse effects of smoking may result from oxidative damage to critical biological substances. 16 Previous reports have demonstrated abnormal endothelial function in chronic smokers, 4,5 and endothelial dysfunction, in turn, has been proposed to play a pathogenetic role in the early manifestation of atheroscleromatous vascular disease 17 and may predict future cardiovascular events. 6,7
Although smoking-induced endothelial dysfunction is very likely multifactorial, more recent clinical and experimental observations strongly point to the potential role of oxygenderived free radicals in mediating this phenomenon. 18, 19 NO is a pivotal endothelium-derived substance, and the hallmark of endothelial dysfunction is impaired endotheliumdependent vasodilatation mediated by NO. Therefore, a OYAMA J et al.
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malfunction in NO production or activity has been proposed as a major mechanism of endothelial dysfunction. The availability of reactive oxygen species allows direct production of cytotoxic species and NO inactivation. 20 ADMA, an endogenous competitive inhibitor of NO synthase, is produced by methylation of arginine residues in intracellular proteins via arginine N-methyltransferase 21, 22 and causes endothelial dysfunction and atherosclerosis. 23 MDA and 4-HNE are the products of lipid peroxidation, which refers to the oxidative degradation of lipids. Therefore, our results indicate that high-dose of GTC induces an improvement in endothelial dysfunction in smokers by increasing NO production and decreasing the levels of ADMA and oxidative stress.
Effect of GTC on Endothelial Dysfunction
In the study by Nagaya et al, endothelial dysfunction evaluated by reactive hyperemia improved in smokers at 2 h after the consumption of 400 ml green tea, 24 and Kim et al found that endothelial dysfunction evaluated by flow-mediated forearm dilatation also improved after daily consumption of 8 g of green tea for 2 weeks, thereby mediating the increased number of endothelial progenitor cells in smokers. 25 However, non-invasive estimation of endothelial function by flowmediated dilation using echography is sometimes technically demanding, hard to standardize and less accurate. 26-28 Moreover, the optimally beneficial amount of green tea and the mechanisms of this phenomenon still remain unclear. In this study, 3 doses of GTC were evaluated ( Table 1) . Most Japanese consume approximately 1 cup of green tea daily on average, which contains approximately 80 mg GTC. More than 580 mg GTC suppresses both the accumulation of body fat and cardiovascular risk in humans. 29 Kuriyama et al suggest that appropriate intake of green tea, equivalent to 5 or 6 cups per day, reduces cardiovascular events, though a low dose of green tea has no effect, 14 which is consistent with the current findings. Therefore, habitual, frequent consumption of green tea is required to achieve these benefits. In addition, it is hard to evaluate the pure effects of GTC in vivo because of the other components of green tea, such as caffeine. Therefore, we investigated the effect of GTC in vivo by using 3 different doses of green tea in which all components other than GTC were the same to avoid any influences of the other components and thus confirmed the dose-dependent effect of GTC through the significant improvement in both FBF and the biochemical markers that influence the progression of the atherosclerosis in vivo.
Epigallocatechin gallate (EGCG), a polyphenol that makes up -30% of the solids in green tea, 30 elicits vasodilation in mesenteric vascular beds, 31 inhibits human platelet aggregation, 32 activates endothelial NO synthase and increases the production of NO in endothelial cells. 33 The current findings, namely that GTC increased the FBF response and NOx level, correlate with the previously published in vivo data. However, the precise mechanisms underlying this risk reduction still remain unknown.
In some epidemiological studies, tea consumption has been reported as associated with a reduced risk for cardiovascular disease. 14, 34 In light of our finding that 2-week therapy with green tea, a catechin-rich beverage, effectively improved endothelial function in male smokers, who are exposed to excessive oxidative stress, we suggests that it is the improvement in endothelial dysfunction in vivo that may reduce cardiovascular events, by reducing oxidative stress and increasing NO production.
Biochemical Alteration of Atherosclerotic, Inflammatory
Markers by GTC MCP-1 plays a pivotal role in the recruitment of monocytes in the development of inflammatory cardiovascular disease and is inhibited by EGCG. 35,36 MIF is produced abundantly by various cells in all types of human atherosclerotic lesions and thus may play an important role in early plaque development and advanced atherogenesis, which is upregulated by CD40L. As a molecule that is detectable in the circulation and at sites of inflammation, MIF might be an indicator of disease severity. 37 sCD40L, which is implicated in atherosclerosis and acute coronary syndrome, is expressed on platelets and released from them on activation. 38 Our results suggest that GCT suppresses the expression of CD40L through de- 
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creasing oxidative stress or inhibiting platelet activation. The relationship between a high level of CRP and cardiovascular risk has been studied extensively in epidemiological studies, in which the role of CRP as a biomarker for vascular risk remained highly significant after adjusting for traditional risk factors. 39, 40 The current results indicate that green tea possesses not only the ability to increase NO production and decrease oxidative stress, but also the antiatherosclerotic, and antiinflammatory effects on the dysfunctional endothelium in smokers.
Study Limitations
The number of subjects in the current study was small and only male healthy smokers whose endothelial function was attenuated because of excessive free radicals were studied. Therefore, we need to carefully examine the beneficial effects of GTC in people who have other cardiovascular risks. However, endothelial dysfunction is observed in patients with cardiovascular disease and cardiovascular risks, which are strongly associated with oxidative stress. 6,8,9 Therefore, GTC may have beneficial effects for patients with other cardiac risk factors.
The specific component of GTC that is responsible and the type of oxidative stress that is affected by GTC was not addressed in the present study. As mentioned previously, EGCG has antioxidant and protective effects for cardiovascular events in vitro and in vivo; 31-34 however, other catechins still remain to be specifically examined.
In this study, the plasma concentrations of GTC were not measured because of technical difficulties in using the general HPLC method. Instead, the intake of all beverages except water and the provided green tea beverage was strictly prohibited during the entire study to avoid any other influences. Finally, the data in the current study are only observatory. Nevertheless, they suggest that green tea has potent beneficial properties on both endothelial dysfunction and aspects of atherosclerosis.
Clinical Implications
Green tea is a low-cost beverage that is consumed worldwide and has potential to protect against oxidative stress, which is strongly associated with the pathogenesis and development of atherosclerotic diseases.
Conclusions
Catechins extracted from green tea had a beneficial impact on vascular endothelial function and that this was mediated by restoring endothelial NO production through a reduction in oxidative stress and many atherosclerotic parameters, thereby supporting previously published epidemiological evidence that green tea reduces cardiovascular risk.
